-
A "turning point in the fight against Alzheimer's"- a new immunotherapy drug, Donanemab, has been trialed and found to reduce clinical decline in people in the early stages of Alzheimer's Disease. Hannah Walton-Hughes reports on this development....
-
February 15, 2025 -
February 14, 2025 -
-
February 14, 2025 -
February 13, 2025